反应条件
1.1: tert.-butyl lithium / hexane; diethyl ether / 4 h / -78 °C / Inert atmosphere 1.2: 0.92 h / -78 - -50 °C / Inert atmosphere 2.1: diisobutylaluminium hydride / toluene / 3 h / -78 °C 2.2: -50 °C 3.1: 4-(N,N-dimethlyamino)pyridine; diisopropyl-carbodiimide / tetrahydrofuran / 24 h / 20 - 40 °C 4.1: RuCl2(tricyclohexylphosphine)2(benzylidene) / dichloromethane / 18 h / 20 - 40 °C / Inert atmosphere 5.1: tetrabutyl ammonium fluoride; ammonium hydrogen difluoride / tetrahydrofuran / 24 h / 20 - 40 °C 6.1: sodium hydride / isopropyl alcohol; mineral oil / 18 h / 20 - 35 °C 6.2: 18 h / 20 °C View Scheme
参考文献
IRIX PHARMACEUTICALS; YIANNIKOUROS, George, Petros; KALARITIS, Panos; GAMAGE, Chaminda, Priyapushpa; ABERNATHY, Stephanie, Bosse
Patent: WO2011/8756 A1, 2011 ;